Implementation of a Chatbot Mobile Health Intervention with Home Spirometry to Monitor Lung Transplant Recipients Remotely

Abstract

<h3>Purpose</h3> The COVID-19 pandemic accelerated the need to develop remote monitoring of graft function in lung transplant (LT) recipients. While home spirometry has been used previously in LT, long-term engagement has been poor. We aimed to improve engagement and allow efficient data and symptom collection using Bluetooth enabled home spirometers coupled with a digital chatbot. <h3>Methods</h3> We implemented an automated, chat-based mobile health intervention via text message or email paired with Bluetooth-enabled hand-held spirometers. The chatbot engaged LT recipients weekly in a personalized, automated chat with symptom assessment, education modules, and spirometer data collection. Clinical team members received automatic notification of concerning symptoms or FEV1 declines of >10%. The correlation between home spirometry FEV1 values and lab-based values were assessed with Pearson's coefficient. <h3>Results</h3> We mailed home spirometers to 424 patients. Between 5/4/2020 and 10/21/2020, 311 patients enrolled in the automated chat and, of these, 273 patients submitted ≥1 FEV1 measure, (median 13; IQR 6-23) over 24 weeks. The largest drop in FEV1 engagement came after the first week in each patient's chat experience; 65% of those that submitted an FEV1 at baseline entered a value at week one and 72% at week two. However, after this initial decline, engagement remained stable through 24 weeks (57-72%, Figure 1.A). Home spirometry FEV1 correlated closely with in-lab spirometry (rho = 0.94) (Figure 1.B) <h3>Conclusion</h3> LT recipients engaged at high rates with a chatbot mobile health intervention and home spirometers to report their FEV1, allowing reliable home-based monitoring of LT recipients. Further investigation will be needed to improve engagement further. Given the projected need for social distancing, and increasing role of telemedicine for long-term management, a chatbot-linked home spirometer may be a powerful tool to detect early graft dysfunction.